GoldenGolden
Vincere Biosciences

Vincere Biosciences

Vincere Biosciences is a company developing drugs to fight Parkinson’s disease and other age-related disorders.

All edits

Edits on 16 Jul, 2019
Carla Faraguna"reformatted and added infobox properties"
Carla Faraguna edited on 16 Jul, 2019
Edits made to:
Infobox (+5/--1 properties)
Description (+65/-50 characters)
Article (+593/-583 characters)
Topic thumbnail

Vincere Biosciences

Vincere Biosciences | Unrelentingis pursuita ofcompany smalldeveloping moleculesdrugs to slow or stopfight Parkinson's’s disease and other age-related disorders.

Article

"There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight." Spring Behrouz, PhD - CEO

Vincere Biosciences is a company developing drugs that can restore mitochondrial quality to slow the progression of Parkinson’s disease and other age-related disorders where deficits in mitochondrial health is known to underlie the disease process.

There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight. -- Spring Behrouz, PhD - CEO
...

Vincere is addressing a large unmet need with 10 million Parkinson's patients worldwide. 90% of pharma are seeking to in-license assets and IND stage acquisitions are valued at an average of $400M. Vincere could reach IND within 3-4 years.

Infobox
Is a
Company
Company status
Active
Parent organization
Andy Lee
Andy Lee edited on 16 Jul, 2019
Edits made to:
Timeline (+19 characters)
Timeline

October 2018

Vincere Biosciences launched by NeuroInitiative to develop small molecules for Parkinson's Disease
Andy Lee
Andy Lee approved a suggestion from Golden's AI on 16 Jul, 2019
Edits made to:
Article (+14/-14 characters)
Article

"There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight." Spring BehrouzSpring Behrouz, PhD - CEO

Andy Lee
Andy Lee edited on 16 Jul, 2019
Edits made to:
Infobox (+1 properties)
Timeline (+3 events) (+467 characters)
Description (+96 characters)
Article (+583 characters)
People (+4 rows) (+8 cells) (+89 characters)
Categories (+4 topics)
Topic thumbnail

Vincere Biosciences

Vincere Biosciences | Unrelenting pursuit of small molecules to slow or stop Parkinson's disease

Article

"There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight." Spring Behrouz, PhD - CEO

...

Vincere is addressing a large unmet need with 10 million Parkinson's patients worldwide. 90% of pharma are seeking to in-license assets and IND stage acquisitions are valued at an average of $400M. Vincere could reach IND within 3-4 years.

People

Name
Role
Related Golden topics

Andy Lee

COO

Bahareh (Spring) Behrouz

CEO

Jim Liang

Board Member & Investor

Kalpana Merchant

CSO

Infobox
Categories
Timeline

May 2019

Michael J Fox Foundation funds $1 million milestone-based project "Discovery and Development of Parkin Activators as Therapies for Parkinson's Disease"

October 16, 2018

Dr. Kalpana Merchant, PhD, former Chief Scientific Officer of Tailored Neuroscience Therapeutics at Eli Lilly, joins Vincere Biosciences as Chief Scientific Officer to develop novel therapeutics targeting mitochondrial qualitity control.

October 2018

Vincere Biosciences launched to develop small molecules for Parkinson's Disease
Andy Lee"Initial topic creation"
Andy Lee created this topic on 16 Jul, 2019
Edits made to:
Topic thumbnail

 Vincere Biosciences

Vincere Biosciences is a company developing drugs to fight Parkinson’s disease and other age-related disorders.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.